Published in
Springer, Diabetes Therapy, 4(9), p. 1511-1532, 2018
DOI: 10.1007/s13300-018-0449-6
Links
Tools
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
Journal article published in 2018 by
Maria J. Pereira,
Per Lundkvist,
Prasad G. Kamble 
,
Joey Lau ,
Julian G. Martins,
C. David Sjöström,
Volker Schnecke,
Anna Walentinsson,
Eva Johnsson,
Jan W. Eriksson
,
Joey Lau ,
Julian G. Martins,
C. David Sjöström,
Volker Schnecke,
Anna Walentinsson,
Eva Johnsson,
Jan W. Eriksson
This paper is made freely available by the publisher.
Full text: Download
Data provided by 